Patients and Caregivers

Sage is rethinking new treatment paths for serious brain disorders.

At Sage, our journey of scientific discovery and development is laser-focused on our mission of transforming the lives of people with life-altering CNS disorders. One of our core values is to put people first, which means we are guided every day by the needs and interests of people with CNS disorders, their caregivers and families.

Clinical Trials

We are exploring new ways to think about and potentially treat serious central nervous system (CNS) disorders. As part of this mission, we conduct clinical trials to determine if our investigational medicines are safe and effective for patients with a particular disease or disorder.

If you would like to learn more about our clinical programs, visit www.sagerx.com/programs-research/clinical-trials or www.clinicaltrials.gov.

We are motivated by the experiences of patients and caregivers

Advocacy

Patient and caregiver perspectives inspire every aspect of our work. Identifying unmet patient needs drives our research and development focus. We are rethinking care and how it is delivered. We also seek to help increase awareness and improve understanding of CNS disorders. Having patients top of mind keeps us grounded in our purpose — to help improve the well-being of individuals and families impacted by CNS diseases.

Expanded Access Program

We understand that, in some cases, patients with serious diseases or conditions may not be eligible for clinical trials and may not have other treatment options. Under very limited circumstances, we will consider making investigational medicines available for individual patients to treat a serious disease or condition outside of a clinical trial. This type of access is often referred to as “expanded access” or “compassionate use.” For more information, see our Expanded Access Program description.